IL92293A - History of '2 - Halomethylidene, 2 '- Ethenylidene and '2 - Ethylenylcitidine, uridine and guanosine and pharmaceutical preparations containing them - Google Patents

History of '2 - Halomethylidene, 2 '- Ethenylidene and '2 - Ethylenylcitidine, uridine and guanosine and pharmaceutical preparations containing them

Info

Publication number
IL92293A
IL92293A IL9229389A IL9229389A IL92293A IL 92293 A IL92293 A IL 92293A IL 9229389 A IL9229389 A IL 9229389A IL 9229389 A IL9229389 A IL 9229389A IL 92293 A IL92293 A IL 92293A
Authority
IL
Israel
Prior art keywords
compound
group
hydrogen
deoxy
halogen
Prior art date
Application number
IL9229389A
Other languages
English (en)
Hebrew (he)
Other versions
IL92293A0 (en
Original Assignee
Merrell Dow Pharmaceuticlas In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticlas In filed Critical Merrell Dow Pharmaceuticlas In
Publication of IL92293A0 publication Critical patent/IL92293A0/xx
Publication of IL92293A publication Critical patent/IL92293A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
IL9229389A 1988-11-15 1989-11-13 History of '2 - Halomethylidene, 2 '- Ethenylidene and '2 - Ethylenylcitidine, uridine and guanosine and pharmaceutical preparations containing them IL92293A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27147988A 1988-11-15 1988-11-15

Publications (2)

Publication Number Publication Date
IL92293A0 IL92293A0 (en) 1990-07-26
IL92293A true IL92293A (en) 1995-01-24

Family

ID=23035764

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9229389A IL92293A (en) 1988-11-15 1989-11-13 History of '2 - Halomethylidene, 2 '- Ethenylidene and '2 - Ethylenylcitidine, uridine and guanosine and pharmaceutical preparations containing them

Country Status (19)

Country Link
EP (1) EP0372268B1 (da)
JP (1) JP2802947B2 (da)
KR (1) KR0144865B1 (da)
CN (1) CN1022248C (da)
AR (1) AR247891A1 (da)
AT (1) ATE105297T1 (da)
AU (1) AU621160B2 (da)
CA (1) CA2002648C (da)
DE (1) DE68915128T2 (da)
DK (1) DK171844B1 (da)
ES (1) ES2056180T3 (da)
FI (1) FI92588C (da)
HU (3) HU205134B (da)
IE (1) IE63563B1 (da)
IL (1) IL92293A (da)
NO (1) NO172240C (da)
NZ (1) NZ231365A (da)
PT (1) PT92309B (da)
ZA (1) ZA898567B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458772B1 (en) 1909-10-07 2002-10-01 Medivir Ab Prodrugs
KR910008800B1 (ko) * 1987-03-19 1991-10-21 야마사 쇼오유 가부시끼가이샤 2'-알킬리덴 피리미딘 누클레오시드 유도체, 그 제조법, 및 그 용도
IE902574A1 (en) * 1989-07-17 1991-02-27 Univ Birmingham Antiviral pyrimidine nucleosides
US5521163A (en) * 1990-07-13 1996-05-28 University Of Birmingham Antiviral pyrimidine nucleosides and methods for using same
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
WO1993022327A1 (en) * 1992-04-23 1993-11-11 Yoshitomi Pharmaceutical Industries, Ltd. 2'-methylidenenucleoside compound and pharmaceutical use thereof
WO1993023414A1 (en) * 1992-05-12 1993-11-25 Merrell Dow Pharmaceuticals Inc. A process for the preparation of ribonucleotide reductase inhibitors
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
NZ258015A (en) * 1992-12-03 1997-01-29 Merrell Dow Pharma Use of acyclovir-like compounds in conjunction with 2'-(halo)methylidene nucleoside analogues in anti-viral treatment
DK0738273T3 (da) * 1994-01-07 2000-04-17 Merrell Pharma Inc Monohydrat af (E) - 2' - (fluormethylen) -- cytidin
US5627053A (en) * 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
WO1996001638A1 (en) * 1994-07-11 1996-01-25 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
EP0770621A4 (en) * 1994-07-12 1998-01-28 Yamasa Corp 2'-DESOXY-2 '- (METHYLIDENE SUBSTITUTED OR NON-SUBSTITUTED) -4'-THIONUCLEOSIDE
US20040006002A1 (en) * 2001-09-28 2004-01-08 Jean-Pierre Sommadossi Methods and compositions for treating flaviviruses and pestiviruses using 4'-modified nucleoside
JP2005522443A (ja) * 2002-02-14 2005-07-28 フアーマセツト・リミテツド 改変フッ素化ヌクレオシド類似体
KR20040036417A (ko) * 2002-10-25 2004-04-30 정낙신 항암 활성을 갖는 티오뉴클레오시드 유도체 및 이를함유하는 약학적 조성물
CN100389119C (zh) * 2004-10-27 2008-05-21 北京东华康明生物科技有限公司 (反式)-2-脱氧-2-(氟亚甲基)-4-r酰胞苷化合物及其制备方法
US9073960B2 (en) 2011-12-22 2015-07-07 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
EP2919792B1 (en) * 2012-11-19 2020-05-20 Merck Sharp & Dohme Corp. 2 -alkynyl substituted nucleoside derivatives for treating viral diseases
WO2018092107A1 (en) * 2016-11-21 2018-05-24 Munisekhar Medasani Novel anti-viral and anti-cancer molecule

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR910008800B1 (ko) * 1987-03-19 1991-10-21 야마사 쇼오유 가부시끼가이샤 2'-알킬리덴 피리미딘 누클레오시드 유도체, 그 제조법, 및 그 용도

Also Published As

Publication number Publication date
PT92309B (pt) 1996-06-28
DE68915128D1 (de) 1994-06-09
HU895900D0 (en) 1990-02-28
CA2002648C (en) 2000-02-29
IL92293A0 (en) 1990-07-26
HU210343A9 (en) 1995-03-28
NZ231365A (en) 1992-08-26
HUT51642A (en) 1990-05-28
DK570089D0 (da) 1989-11-14
CN1022248C (zh) 1993-09-29
JP2802947B2 (ja) 1998-09-24
NO894539L (no) 1990-05-16
IE63563B1 (en) 1995-05-17
PT92309A (pt) 1990-05-31
AU4461189A (en) 1990-05-24
KR0144865B1 (ko) 1998-07-01
NO894539D0 (no) 1989-11-14
ATE105297T1 (de) 1994-05-15
DK570089A (da) 1990-05-16
HU205134B (en) 1992-03-30
JPH02178272A (ja) 1990-07-11
AU621160B2 (en) 1992-03-05
NO172240B (no) 1993-03-15
ZA898567B (en) 1990-08-29
EP0372268B1 (en) 1994-05-04
IE893651L (en) 1990-05-15
FI92588B (fi) 1994-08-31
AR247891A1 (es) 1995-04-28
EP0372268A1 (en) 1990-06-13
ES2056180T3 (es) 1994-10-01
CA2002648A1 (en) 1990-05-15
DE68915128T2 (de) 1994-08-25
CN1042715A (zh) 1990-06-06
FI895417A0 (fi) 1989-11-14
FI92588C (fi) 1994-12-12
NO172240C (no) 1993-06-23
HU00045A9 (en) 1995-01-30
DK171844B1 (da) 1997-06-30
KR900007833A (ko) 1990-06-02

Similar Documents

Publication Publication Date Title
CA2002648C (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
US5616702A (en) 2-'-ethenylidene cytidine, uridine and guanosine derivatives
US20030109484A1 (en) Novel 2'-halomethylidene, 2'-ethenylidene and 2'ethynyl cytidine, uridine and guanosine derivatives
WO1990012023A1 (en) Antiviral compounds
KR950006713B1 (ko) 6-치환 비환식 피리미딘뉴클레오시드 유도체 및 그 유도체를 유효성분으로 하는 항 비루스제
CA1336903C (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives
JPH06228186A (ja) 2’−デオキシ−(2’s)−アルキルピリミジンヌクレオシド誘導体
CA2132303A1 (en) Antiviral phosphonic acid derivatives of purine analogues
US5607925A (en) Treatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosides
EP0335770B1 (en) Novel fluorophosphonate nucleotide derivatives
US6017923A (en) Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.